000			01454 a2200397 4500
005			20250517011103.0
264		0	_c20160129
008			201601s 0 0 eng d
022			_a1878-5832
024	7		_a10.1016/j.drudis.2014.12.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aJordan, Allan M
245	0	0	_aRethinking 'academic' drug discovery: the Manchester Institute perspective. _h[electronic resource]
260			_bDrug discovery today _cMay 2015
300			_a525-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAcademies and Institutes _xorganization & administration
650	0	4	_aAntineoplastic Agents _xchemistry
650	0	4	_aCooperative Behavior
650	0	4	_aDrug Discovery _xmethods
650	0	4	_aEngland
650	0	4	_aHumans
650	0	4	_aModels, Organizational
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aProgram Development
650	0	4	_aResearch Personnel _xorganization & administration
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTranslational Research, Biomedical _xmethods
650	0	4	_aWorkflow
700	1		_aWaddell, Ian D
700	1		_aOgilvie, Donald J
773	0		_tDrug discovery today _gvol. 20 _gno. 5 _gp. 525-35
856	4	0	_uhttps://doi.org/10.1016/j.drudis.2014.12.011 _zAvailable from publisher's website
999			_c24490062 _d24490062